The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure
Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
Carperitide (alpha-human atrial natriuretic peptide) improves systemic hemodynamics in
patients with heart failure through a vasodilatory action, a natriuretic action, and
inhibition of the renin-angiotensin-aldosterone system and has been widely-used in Japan.
However, a paucity of report is available on the effects of carperitide on short and
long-term prognosis in patients with both cardiac and renal failure. The purpose of this
study is to evaluate the effects of carperitide therapy on short and long-term prognosis in
patients with both cardiac and renal failure, in comparison with standard therapy.